SCARLETRED is once again at the forefront of innovation in digital dermatology. Our poster, “Injection Site Reaction Monitoring Reimagined: AI-Powered Detection and Inclusive Quantification,” has been selected for presentation at the upcoming ESDR 2025 Conference.

This research showcases how cutting-edge AI and advanced image processing can transform how injection site reactions (ISRs) are detected, quantified, and monitored. Our approach delivers objective, standardized, and inclusive assessments across all skin types, setting a new benchmark for clinical studies and patient safety.

The technology enables researchers to collect high-quality, consistent data across diverse populations, accelerating clinical trials and regulatory approvals. For patients, it ensures more accurate monitoring, early detection of adverse reactions, and ultimately, safer, more personalized treatments.

ISRs can be early warning signs of serious adverse events. When overlooked, especially in vaccines or biologics, they may lead to severe, even life-threatening complications. Our AI-powered platform strengthens safety surveillance by providing timely, reliable insights that support earlier clinical decisions and help prevent escalation.

Fully integrated into the Scarletred® Vision platform, this innovation equips researchers and clinicians with next-generation tools for digital dermatology and drug safety - enhancing patient safety, speeding up development, and delivering better care.

‍

👉 Learn more about the conference here 

‍